Events

ESMO 2021: KRYSTAL-1 Study

By ONA Editor September 23, 2021 No Comments

Highlights on adagrasib in patients with KRASG12C-mutated colorectal cancer: The KRYSTAL-1 study

About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

About Author

Related Posts

S4 E3:‘Mouthwatering’ RAS(ON), Bob Marley’s Melanoma, ADT Hot Flushes + Prostate Cancer Terminology

AACR 2026: Sleep deprivation disrupts gut microbiota, worsening colorectal cancer outcomes

AACR 2026: Exposure to wildfire smoke may be linked to increased risk of developing several cancers

Leave A Reply Cancel Reply